Skip to main content

Innate Immune Responses to Hepatitis C Virus

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 369))

Abstract

The innate immune response provides the first line of defense against invading viral pathogens. Incoming viruses are sensed by dedicated host factors that, when triggered, initiate multiple signal transduction pathways. Activation of these pathways leads to the induction of highly orchestrated transcriptional programs designed to limit virus replication and spread. In recent years, our understanding of innate immune responses targeting hepatitis C virus (HCV) has increased substantially, largely due to the development of new systems and methodologies to study HCV–host interactions in vitro and in vivo. However, significant gaps still remain. Here, we aim to provide a comprehensive view of the innate immune response to HCV, focusing primarily on knowledge gained from cell culture models of HCV infection, as well as data from human patients infected with HCV. While some paradigms of the host response to HCV revealed in cell culture translate to human infection in vivo, others are less clear. Further insight into the similarities and differences in these systems will not only reveal directions for future studies on HCV immunity, but may also guide the development of novel strategies to control HCV and other viral infections.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abbate I, Romano M, Longo R, Cappiello G, Lo Iacono O, Di Marco V, Paparella C, Spano A, Capobianchi MR (2003) Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients. J Med Virol 70:581–587. doi:10.1002/jmv.10433

    Article  CAS  PubMed  Google Scholar 

  • Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Nakamura Y, Chayama K (2011) IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol 54:1094–1101. doi:10.1016/j.jhep.2010.09.019

    Article  CAS  PubMed  Google Scholar 

  • Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM (2011) Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology 54:1901–1912. doi:10.1002/hep.24557

    Article  CAS  PubMed  Google Scholar 

  • Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, Wakita T, Meurs EF (2011) Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog 7:e1002289. doi:10.1371/journal.ppat.1002289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Asahina Y, Tsuchiya K, Muraoka M, Tanaka K, Suzuki Y, Tamaki N, Hoshioka Y, Yasui Y, Katoh T, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Nitta S, Sakamoto N, Izumi N (2012) Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology 55:20–29. doi:10.1002/hep.24623

    Article  CAS  PubMed  Google Scholar 

  • Baril M, Racine ME, Penin F, Lamarre D (2009) MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83:1299–1311. doi:10.1128/JVI.01659-08

    Article  CAS  PubMed  Google Scholar 

  • Bartenschlager R, Lohmann V (2000) Replication of hepatitis C virus. J Gen Virol 81:1631–1648

    Article  CAS  PubMed  Google Scholar 

  • Bellecave P, Sarasin-Filipowicz M, Donze O, Kennel A, Gouttenoire J, Meylan E, Terracciano L, Tschopp J, Sarrazin C, Berg T, Moradpour D, Heim MH (2010) Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology 51:1127–1136. doi:10.1002/hep.23426

    Article  CAS  PubMed  Google Scholar 

  • Bigger CB, Brasky KM, Lanford RE (2001) DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75:7059–7066. doi:10.1128/JVI.75.15.7059-7066.2001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Binder M, Kochs G, Bartenschlager R, Lohmann V (2007) Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46:1365–1374. doi:10.1002/hep.21829

    Article  CAS  PubMed  Google Scholar 

  • Binder M, Eberle F, Seitz S, Mucke N, Huber CM, Kiani N, Kaderali L, Lohmann V, Dalpke A, Bartenschlager R (2011) Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Bio Chem 286:27278–27287. doi:10.1074/jbc.M111.256974

    Article  CAS  Google Scholar 

  • Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290:1972–1974

    Article  CAS  PubMed  Google Scholar 

  • Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76:13001–13014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, Gerken G, Schlaak JF (2010) The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59:1111–1119. doi:10.1136/gut.2009.195545

    Article  CAS  PubMed  Google Scholar 

  • Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G (2005) Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 79:13963–13973. doi:10.1128/JVI.79.22.13963-13973.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J (2011) Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 53:317–324. doi:10.1002/hep.24074

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM, McGilvray ID (2005) Hepatic gene expression discriminates responders and non-responders in treatment of chronic hepatitis C viral infection. Gastroenterology 128:1437–1444

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID (2010) ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. J Gen Virol 91:382–388. doi:10.1099/vir.0.015388-0

    Article  CAS  PubMed  Google Scholar 

  • Choi SS, Bradrick S, Qiang G, Mostafavi A, Chaturvedi G, Weinman SA, Diehl AM, Jhaveri R (2011) Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication. Hepatology 54:1580–1590. doi:10.1002/hep.24576

    Article  CAS  PubMed  Google Scholar 

  • Chung RT, He W, Saquib A, Contreras AM, Xavier RJ, Chawla A, Wang TC, Schmidt EV (2001) Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system. Proc Natl Acad Sci USA 98:9847–9852. doi:10.1073/pnas.171319698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coto-Llerena M, Perez-Del-Pulgar S, Crespo G, Carrion JA, Martinez SM, Sanchez-Tapias JM, Martorell J, Navasa M, Forns X (2011) Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation. Am J Transplant (Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons) 11:1051–1057. doi:10.1111/j.1600-6143.2011.03491.x

    Article  CAS  Google Scholar 

  • Crampton SP, Deane JA, Feigenbaum L, Bolland S (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188:1451–1459. doi:10.4049/jimmunol.1102705

    Article  CAS  PubMed  Google Scholar 

  • Dansako H, Ikeda M, Kato N (2007) Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes. FEBS J 274:4161–4176. doi:10.1111/j.1742-4658.2007.05942.x

    Article  CAS  PubMed  Google Scholar 

  • Dansako H, Ikeda M, Ariumi Y, Wakita T, Kato N (2009) Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases. Arch Virol 154:801–810. doi:10.1007/s00705-009-0375-z

    Article  CAS  PubMed  Google Scholar 

  • Dill MT, Duong FH, Vogt JE, Bibert S, Bochud PY, Terracciano L, Papassotiropoulos A, Roth V, Heim MH (2011) Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterol 140:1021–1031. doi:10.1053/j.gastro.2010.11.039, S0016-5085(10)01729-4 (pii)

  • Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC (2010) Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668–681. doi:10.1016/j.cell.2010.04.018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eksioglu EA, Zhu H, Bayouth L, Bess J, Liu HY, Nelson DR, Liu C (2011) Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells. PLoS One 6:e21186. doi:10.1371/journal.pone.0021186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eurich D, Boas-Knoop S, Ruehl M, Schulz M, Carrillo ED, Berg T, Neuhaus R, Neuhaus P, Neumann UP, Bahra M (2011) Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation. Liver Transplant (Official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society) 17:289–298. doi:10.1002/lt.22235

    Article  Google Scholar 

  • Feigelstock DA, Mihalik KB, Kaplan G, Feinstone SM (2010) Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I. Virol J 7:44. doi:10.1186/1743-422X-7-44

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496. doi:10.1038/ni921

    Article  CAS  PubMed  Google Scholar 

  • Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145–1148. doi:10.1126/science.1082604

    Article  CAS  PubMed  Google Scholar 

  • Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M Jr (2008) Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82:609–616. doi:10.1128/JVI.01305-07

    Article  CAS  PubMed  Google Scholar 

  • Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R (2001) Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82:723–733

    Article  CAS  PubMed  Google Scholar 

  • Fukuhara T, Taketomi A, Motomura T, Okano S, Ninomiya A, Abe T, Uchiyama H, Soejima Y, Shirabe K, Matsuura Y, Maehara Y (2010) Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology 139:1577–1585, 1585 e1-3. doi: 10.1053/j.gastro.2010.07.058

  • Garaigorta U, Chisari FV (2009) Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6:513–522. doi:10.1016/j.chom.2009.11.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401. doi: 10.1038/nature08309, nature08309 (pii)

  • Guo JT, Bichko VV, Seeger C (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75:8516–8523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He XS, Ji X, Hale MB, Cheung R, Ahmed A, Guo Y, Nolan GP, Pfeffer LM, Wright TL, Risch N, Tibshirani R, Greenberg HB (2006) Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 44:352–359. doi:10.1002/hep.21267

    Article  CAS  PubMed  Google Scholar 

  • Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR (2005) Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42:702–710. doi:10.1002/hep.20844

    Article  CAS  PubMed  Google Scholar 

  • Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, McCartney EM, Jangra RK, Lemon SM, Beard MR (2011) The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 54:1506–1517. doi:10.1002/hep.24542

    Article  CAS  PubMed  Google Scholar 

  • Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Nakamura M, Shirasaki T, Horimoto K, Tanaka Y, Tokunaga K, Mizokami M, Kaneko S (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139:499–509. doi: 10.1053/j.gastro.2010.04.049, S0016-5085(10)00657-8 (pii)

  • Horner SM, Gale M Jr (2009) Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res (The Official Journal of the International Society for Interferon and Cytokine Research) 29:489–498. doi:10.1089/jir.2009.0063

    Article  CAS  Google Scholar 

  • Horner SM, Liu HM, Park HS, Briley J, Gale M Jr (2011) Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci USA 108:14590–14595. doi:10.1073/pnas.1110133108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Horner SM, Park HS, Gale M Jr (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix alpha0. J Virol 86:3112–3120. doi:10.1128/JVI.06727-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G (2006) 5’-Triphosphate RNA is the ligand for RIG-I. Science 314:994–997. doi:10.1126/science.1132505

    Article  PubMed  Google Scholar 

  • Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ (2011) MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448–461. doi:10.1016/j.cell.2011.06.041

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang Y, Feld JJ, Sapp RK, Nanda S, Lin JH, Blatt LM, Fried MW, Murthy K, Liang TJ (2007) Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology 132:733–744. doi:10.1053/j.gastro.2006.11.045

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674–678. doi:10.1038/nature07317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ishikawa H, Ma Z, Barber GN (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788–792. doi:10.1038/nature08476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, Maekawa S, Enomoto N, Watanabe M (2006) Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13: 690–700. doi: 10.1111/j.1365-2893.2006.00732.x, JVH732 (pii)

  • Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M (2009) Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727–1737. doi:10.1002/hep.23195

    Article  CAS  PubMed  Google Scholar 

  • Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT (2008) Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82:1665–1678. doi:10.1128/JVI.02113-07, JVI.02113-07 (pii)

  • Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M Jr, Patel SS, Marcotrigiano J (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479:423–427. doi:10.1038/nature10537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson CL, Owen DM, Gale M Jr (2007) Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 282:10792–10803. doi:10.1074/jbc.M610361200

    Article  CAS  PubMed  Google Scholar 

  • Jouan L, Melancon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Boucher G, Bilodeau M, Grandvaux N, Lamarre D (2010) Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease. J Hepatol 52:167–175. doi:10.1016/j.jhep.2009.11.011

    Article  CAS  PubMed  Google Scholar 

  • Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M (2004) Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 78:9713–9720. doi:10.1128/JVI.78.18.9713-9720.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kato T, Esumi M, Yamashita S, Abe K, Shikata T (1992) Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus. Virology 190:856–860

    Article  CAS  PubMed  Google Scholar 

  • Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981–988. doi:10.1038/ni1243

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki T, Kawai T, Akira S (2011) Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 243:61–73. doi:10.1111/j.1600-065X.2011.01048.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ke PY, Chen SS (2011) Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Investig 121:37–56. doi:10.1172/JCI41474

    Article  CAS  PubMed  Google Scholar 

  • Keating SE, Baran M, Bowie AG (2011) Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol 32:574–581. doi:10.1016/j.it.2011.08.004

    Article  CAS  PubMed  Google Scholar 

  • Koshiba T, Yasukawa K, Yanagi Y, Kawabata S (2011) Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signaling 4 (ra7) doi: 10.1126/scisignal.2001147

  • Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69–77. doi:10.1038/ni875

    Article  CAS  PubMed  Google Scholar 

  • Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423–435. doi:10.1016/j.cell.2011.09.039

    Article  CAS  PubMed  Google Scholar 

  • Kumar H, Kawai T, Akira S (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388:621–625. doi:10.1016/j.bbrc.2009.08.062

    Article  CAS  PubMed  Google Scholar 

  • Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, Bonneau P, Bos M, Cameron DR, Cartier M, Cordingley MG, Faucher AM, Goudreau N, Kawai SH, Kukolj G, Lagace L, LaPlante SR, Narjes H, Poupart MA, Rancourt J, Sentjens RE, St George R, Simoneau B, Steinmann G, Thibeault D, Tsantrizos YS, Weldon SM, Yong CL, Llinas-Brunet M (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186–189. doi:10.1038/nature02099

    Article  CAS  PubMed  Google Scholar 

  • Lanford RE, Guerra B, Lee H, Averett DR, Pfeiffer B, Chavez D, Notvall L, Bigger C (2003) Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77:1092–1104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lanford RE, Guerra B, Bigger CB, Lee H, Chavez D, Brasky KM (2007) Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus. Hepatology 46:999–1008. doi:10.1002/hep.21776

    Article  CAS  PubMed  Google Scholar 

  • Lavanchy D (2009) The global burden of hepatitis C. Liver Int (Official Journal of the International Association for the Study of the Liver) 29(Suppl 1):74–81. doi:10.1111/j.1478-3231.2008.01934.x

    Article  Google Scholar 

  • Lempicki RA, Polis MA, Yang J, McLaughlin M, Koratich C, Huang DW, Fullmer B, Wu L, Rehm CA, Masur H, Lane HC, Sherman KE, Fauci AS, Kottilil S (2006) Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 193:1172–1177. doi:10.1086/501365

    Article  CAS  PubMed  Google Scholar 

  • Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM (2005a) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102:2992–2997. doi:10.1073/pnas.0408824102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li XD, Sun L, Seth RB, Pineda G, Chen ZJ (2005b) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 102:17717–17722. doi:10.1073/pnas.0508531102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li K, Li NL, Wei D, Pfeffer SR, Fan M, Pfeffer LM (2012) Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatology 55:666–675. doi:10.1002/hep.24763

    Article  CAS  PubMed  Google Scholar 

  • Liang Y, Ishida H, Lenz O, Lin TI, Nyanguile O, Simmen K, Pyles RB, Bourne N, Yi M, Li K, Lemon SM (2008) Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors. Gastroenterology 135(1710–1718):e2. doi:10.1053/j.gastro.2008.07.023

    Article  CAS  Google Scholar 

  • Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623–626. doi:10.1126/science.1114016

    Article  CAS  PubMed  Google Scholar 

  • Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, Norkrans G, Soderholm J, Wahlberg T, Wejstal R, Westin J, Hellstrand K (2011) IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. J Viral Hepatitis 18:e325–e331. doi:10.1111/j.1365-2893.2010.01425.x

    Article  CAS  Google Scholar 

  • Loo YM, Gale M Jr (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680–692. doi:10.1016/j.immuni.2011.05.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM (2011) Structural insights into RNA recognition by RIG-I. Cell 147:409–422. doi:10.1016/j.cell.2011.09.023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manuse MJ, Parks GD (2010) TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology 397:231–241. doi:10.1016/j.virol.2009.11.014

    Article  CAS  PubMed  Google Scholar 

  • Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, Rice CM (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131:1887–1898. doi:10.1053/j.gastro.2006.09.052

    Article  PubMed  Google Scholar 

  • Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54:1913–1923. doi:10.1002/hep.24580

    Article  CAS  PubMed  Google Scholar 

  • McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, Fischer S, Borozan I, Xie G, Selzner N, Heathcote EJ, Siminovitch K (2012) Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype. Gastroenterology 142(1122–1131):e1. doi:10.1053/j.gastro.2012.01.028

    Article  CAS  Google Scholar 

  • McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS (2009) Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. New Engl J Medicine 361:580–593. doi:10.1056/NEJMoa0808010

    Article  CAS  Google Scholar 

  • Meier V, Mihm S, Ramadori G (2000) M×A gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha. J Med Virol 62:318–326

    Article  CAS  PubMed  Google Scholar 

  • Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R (2012) Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology. doi:10.1002/hep.25908

    Article  PubMed  Google Scholar 

  • Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172. doi:10.1038/nature04193

    Article  CAS  PubMed  Google Scholar 

  • Mihm S, Frese M, Meier V, Wietzke-Braun P, Scharf JG, Bartenschlager R, Ramadori G (2004) Interferon type I gene expression in chronic hepatitis C. Laboratory investigation. J Tech Methods Pathol 84:1148–1159. doi:10.1038/labinvest.3700135

    Article  CAS  Google Scholar 

  • Motomura T, Taketomi A, Fukuhara T, Mano Y, Takeishi K, Toshima T, Harada N, Uchiyama H, Yoshizumi T, Soejima Y, Shirabe K, Matsuura Y, Maehara Y (2011) The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft case. Am J Transplant (Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons) 11:1325–1329. doi:10.1111/j.1600-6143.2011.03537.x

    Article  CAS  Google Scholar 

  • Murashima S, Kumashiro R, Ide T, Miyajima I, Hino T, Koga Y, Ishii K, Ueno T, Sakisaka S, Sata M (2000) Effect of interferon treatment on serum 2’,5’-oligoadenylate synthetase levels in hepatitis C-infected patients. J Med Virol 62:185–190

    Article  CAS  PubMed  Google Scholar 

  • Naggie S, Osinusi A, Katsounas A, Lempicki R, Herrmann E, Thompson AJ, Clark PJ, Patel K, Muir AJ, McHutchison JG, Schlaak JF, Trippler M, Shivakumar B, Masur H, Polis MA, Kottilil S (2012) Dysregulation of innate immunity in HCV genotype 1 IL28B unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology. doi:10.1002/hep.25647

    Article  PubMed  Google Scholar 

  • O’Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7:353–364. doi:10.1038/nri2079

    Article  CAS  PubMed  Google Scholar 

  • Onoguchi K, Onomoto K, Takamatsu S, Jogi M, Takemura A, Morimoto S, Julkunen I, Namiki H, Yoneyama M, Fujita T (2010) Virus-infection or 5’ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6:e1001012. doi:10.1371/journal.ppat.1001012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel MR, Loo YM, Horner SM, Gale M Jr, Malik HS (2012) Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol 10:e1001282. doi:10.1371/journal.pbio.1001282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pestka S (2007) The interferons: 50 years after their discovery, there is much more to learn. J Bio Chem 282:20047–20051. doi:10.1074/jbc.R700004200

    Article  CAS  Google Scholar 

  • Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314:997–1001. doi:10.1126/science.1132998

    Article  CAS  PubMed  Google Scholar 

  • Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013 Jan 6, doi: 10.1038/ng.2521

  • Ramachandran A, Horvath CM (2009) Paramyxovirus disruption of interferon signal transduction: status report. J Interferon Cytokine Res (The Official journal of the International Society for Interferon and Cytokine Research) 29:531–537. doi:10.1089/jir.2009.0070

    Article  CAS  Google Scholar 

  • Randall G, Chen L, Panis M, Fischer AK, Lindenbach BD, Sun J, Heathcote J, Rice CM, Edwards AM, McGilvray ID (2006) Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131:1584–1591. doi:10.1053/j.gastro.2006.08.043

    Article  CAS  PubMed  Google Scholar 

  • Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Gunthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338–1345, 1345 (e1-7). doi: 10.1053/j.gastro.2009.12.056

  • Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85:12881–12889. doi:10.1128/JVI.05633-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, Schoenemeyer A, Yamamoto M, Akira S, Fitzgerald KA (2005) The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175:5260–5268

    Article  CAS  PubMed  Google Scholar 

  • Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523–527. doi:10.1038/nature07106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, Heim MH (2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 105:7034–7039. doi:10.1073/pnas.0707882105

    Article  PubMed  PubMed Central  Google Scholar 

  • Sarasin-Filipowicz M, Wang X, Yan M, Duong FH, Poli V, Hilton DJ, Zhang DE, Heim MH (2009) Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol 29:4841–4851. doi: 10.1128/MCB.00224-09, MCB.00224-09 (pii)

  • Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107:1512–1517. doi:10.1073/pnas.0912986107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481–485. doi:10.1038/nature09907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scott J, Holte S, Urban T, Burgess C, Coppel E, Wang C, Corey L, McHutchison J, Goldstein D (2011) IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection. J Infect Dis 204:419–425. doi:10.1093/infdis/jir264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682. doi:10.1016/j.cell.2005.08.012

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Tenoever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151. doi:10.1126/science.1081315

    Article  CAS  PubMed  Google Scholar 

  • Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63–68. doi:10.1038/ni873

    Article  CAS  PubMed  Google Scholar 

  • Shin EC, Seifert U, Kato T, Rice CM, Feinstone SM, Kloetzel PM, Rehermann B (2006) Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Investig 116:3006–3014. doi:10.1172/JCI29832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG (2003) Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 38:1458–1467. doi:10.1016/j.hep.2003.09.024

    Article  CAS  PubMed  Google Scholar 

  • Stark GR, Darnell JE Jr (2012) The JAK-STAT pathway at twenty. Immunity 36:503–514. doi:10.1016/j.immuni.2012.03.013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, Chisari FV (2002) Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99:15669–15674. doi:10.1073/pnas.202608199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689–2699. doi:10.1128/JVI.79.5.2689-2699.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100–1104. doi: 10.1038/ng.447, ng.447 (pii)

  • Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105–1109. doi: 10.1038/ng.449, ng.449 (pii)

  • Tang ED, Wang CY (2009) MAVS self-association mediates antiviral innate immune signaling. J Virol 83:3420–3428. doi:10.1128/JVI.02623-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH (2007) Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 81:3391–3401. doi:10.1128/JVI.02640-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thimme R, Binder M, Bartenschlager R (2012) Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev 36:663–683. doi:10.1111/j.1574-6976.2011.00319.x

    Article  CAS  PubMed  Google Scholar 

  • Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798–801. doi:10.1038/nature08463, nature08463 (pii)

  • Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, Rotman Y, Liang TJ (2012) HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 142:978–988. doi:10.1053/j.gastro.2011.12.055

    Article  CAS  PubMed  Google Scholar 

  • Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee WM, Reindollar R, King JW, Kwo PY, Ghalib RH, Freilich B, Nyberg LM, Zeuzem S, Poynard T, Vock DM, Pieper KS, Patel K, Tillmann HL, Noviello S, Koury K, Pedicone LD, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG (2010) Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 139(120–9):e18. doi:10.1053/j.gastro.2010.04.013

    Article  CAS  Google Scholar 

  • Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997–1004. doi:10.1038/ni.1932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, Cronin KD, Hong L, McKenzie A, Patel K, Shianna KV, McHutchison JG, Goldstein DB, Afdhal N (2010) IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52:1888–1896. doi:10.1002/hep.23912

    Article  CAS  PubMed  Google Scholar 

  • Uze G, Schreiber G, Piehler J, Pellegrini S (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316:71–95

    CAS  PubMed  Google Scholar 

  • Vilasco M, Larrea E, Vitour D, Dabo S, Breiman A, Regnault B, Riezu JI, Eid P, Prieto J, Meurs EF (2006) The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers. Hepatology 44:1635–1647. doi:10.1002/hep.21432

    Article  CAS  PubMed  Google Scholar 

  • Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, Zhu LF, Gao TJ, Kneteman NM, Tyrrell DL, Katze MG (2006) Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog 2:e59. doi:10.1371/journal.ppat.0020059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang C, Pflugheber J, Sumpter R Jr, Sodora DL, Hui D, Sen GC, Gale M Jr (2003) Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77:3898–3912

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, Li K (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol 83:9824–9834. doi:10.1128/JVI.01125-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang S, Wu X, Pan T, Song W, Wang Y, Zhang F, Yuan Z (2012) Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. J Gen Virol 93:83–92. doi:10.1099/vir.0.033860-0

    Article  CAS  PubMed  Google Scholar 

  • Welsch C, Jesudian A, Zeuzem S, Jacobson I (2012) New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives. Gut 61(Suppl 1):i36–i46. doi:10.1136/gutjnl-2012-302144

    Article  CAS  PubMed  Google Scholar 

  • Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740. doi:10.1016/j.molcel.2005.08.014

    Article  CAS  PubMed  Google Scholar 

  • Yang D, Liu N, Zuo C, Lei S, Wu X, Zhou F, Liu C, Zhu H (2011) Innate host response in primary human hepatocytes with hepatitis C virus infection. PLoS One 6:e27552. doi:10.1371/journal.pone.0027552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737. doi:10.1038/ni1087

    Article  CAS  PubMed  Google Scholar 

  • Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M Jr, Akira S, Yonehara S, Kato A, Fujita T (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851–2858

    Article  CAS  PubMed  Google Scholar 

  • Zhao H, Lin W, Kumthip K, Cheng D, Fusco DN, Hofmann O, Jilg N, Tai AW, Goto K, Zhang L, Hide W, Jang JY, Peng LF, Chung RT (2012) A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus. J Hepatol 56:326–333. doi:10.1016/j.jhep.2011.07.026

    Article  CAS  PubMed  Google Scholar 

  • Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C (2003) Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37:1180–1188. doi:10.1053/jhep.2003.50184

    Article  CAS  PubMed  Google Scholar 

  • Zhu H, Butera M, Nelson DR, Liu C (2005) Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J 2:80. doi:10.1186/1743-422X-2-80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to John W. Schoggins or Charles M. Rice .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schoggins, J.W., Rice, C.M. (2013). Innate Immune Responses to Hepatitis C Virus. In: Bartenschlager, R. (eds) Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Current Topics in Microbiology and Immunology, vol 369. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27340-7_9

Download citation

Publish with us

Policies and ethics